Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03296592 · ClinicalTrials.gov registry record
Diffusion MRI in Cervical Spondylotic Myelopathy (CSM)
A clinical trial, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- 71
- Enrollment target
NCT03296592: Completed study, sponsored by Washington University School of Medicine.
NCT03296592 is a clinical trial that has completed, run by Washington University School of Medicine. The registered enrollment target is 71 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03296592 has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- 71 participants
- Enrollment target
Study Summary
Patients who have been diagnosed with Cervical Spondylotic Myelopathy will be asked to undergo an MRI using diffusion basis spectrum imaging (DBSI) technology. The patients will have this MRI preoperatively and at 24 months postop. The investigators believe that with this imaging, biomarkers will be able to be seen to assist in prediction of long term outcomes in patients with spinal cord compression. These patients will be compared to healthy cohorts who will also undergo an MRI using the DBSI technology.
Primary Outcome
Outcome measure will assess spinal cord DBSI pathological metrics at baseline and at 24 months.
Interventions
- DIAGNOSTIC_TEST MRI with DBSI technology
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 71 participants |
| Start Date | 2018-01-29 |
| Est. Completion | 2025-12-29 |
What the finished NCT03296592 record still lists
NCT03296592 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 71 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which MRI with DBSI technology is the first listed.
NCT03296592 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03296592 about?
NCT03296592 is a clinical study titled "Diffusion MRI in Cervical Spondylotic Myelopathy (CSM)". Patients who have been diagnosed with Cervical Spondylotic Myelopathy will be asked to undergo an MRI using diffusion basis spectrum imaging (DBSI) technology. The patients will have this MRI preoperatively and at 24 months postop. The investigators believe that with this imaging, biomarkers will be...
What is the current status of trial NCT03296592?
This trial is currently completed. The enrollment target is 71 participants. The study started on 2018-01-29. Estimated completion is 2025-12-29.
What interventions are being tested in trial NCT03296592?
The interventions under investigation include: MRI with DBSI technology (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03296592?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05452889 · 71 participants · Early Phase 1
PET Image in PAH Patients
- NCT05766943 · 71 participants · NA
Reduction of Myopotential Interference With Smart Pass in S-ICD Patients
- NCT06229678 · 71 participants · Early Phase 1
Ketones, SGLT2, HFrEF
- NCT06377566 · 71 participants · Phase 2
A Study of BV-AVD in People With Bulky Hodgkin Lymphoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI